Background & Sources: Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview — Research Summary

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.